Last Updated : October 5, 2012
Details
FilesGeneric Name:
Pirfenidone
Project Status:
Complete
Therapeutic Area:
Idiopathic pulmonary fibrosis
Manufacturer:
InterMune Canada Inc.
Call for patient/clinician input open:
Brand Name:
Esbriet
Project Line:
Reimbursement Review
Project Number:
SR0292-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Pulmonary fibrosis (idiopathic, mild to moderate)
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : October 5, 2012